Skip to main content

Table 1 Demographic and clinical characteristics

From: Multi-level integrative analysis of the roles of lncRNAs and differential mRNAs in the progression of chronic pancreatitis to pancreatic ductal adenocarcinoma

Patients

Diagnoses

Age

Gender

Height (cm)

Weight (kg)

HBP

DM

ASA

Hb

(g/dL)

CRP (mg/L)

CA199

(U/mL)

A

PDAC

70

Male

158

62

N

+

2

14.0

49.5

164.8

B

PDAC

62

Female

155

40

N

N

1

12.3

82.8

20.3

C

PDAC

53

Male

160

55

+

N

1

15.8

121.8

10.6

D

CP

46

Female

153

47

N

N

1

12.6

22.3

12.8

E

CP

47

Male

165

64

N

N

1

13.7

19.3

13.9

F

CP

41

Female

155

61

N

N

1

13.4

51.0

5.2

  1. PDAC, pancreatic ductal adenocarcinoma; CP, chronic pancreatitis; HBP, hypertension; DM, diabetes mellitus; ASA, American Society of Anesthesiologists; Hb, hemoglobin; CRP, C-reactive protein; CA199: Carbohydrate antigen 199.